MONOCLONAL ANTIBODY THERAPY AVAILABLE
Cough & Fever Clinic is currently a treatment facility for patients with an appointment for monoclonal antibody (mAb) therapy. The clinic no longer accepts walk-in appointments for COVID-19 testing. Cough & Fever Clinic welcomes referrals for mAb therapy. Additionally, all mAb therapy appointments must be scheduled prior to arrival.
Monoclonal antibodies, or mAbs, are laboratory-made proteins that help the body fight the virus that causes COVID-19. MAbs infusions can help ease severe COVID-19 symptoms and potentially reduce hospitalizations and deaths. The mAb therapy is the first COVID-19 treatment granted emergency use authorization by the U.S. Food and Drug Administration for outpatient use. A Phase 3 clinical trial showed that the antibody therapy reduced the risk of hospitalization or death by up to 70% in patients who received the drug intravenously compared to those who received a placebo.
Patients who have tested positive and developed COVID-19 symptoms within the last 7 days may qualify for this therapy. Additionally, patients must be at least 12 years old, weigh more than 88 lbs., not require oxygen for COVID-19, and be 65 or older or have at least one qualifying medical condition such as:
- Hypertension or other heart disease
- Lung disease
- Kidney disease
- Sickle cell disease
- Immunosuppressive disease/ therapy
- Neurodevelopmental disorder
- Have medical-related technologic dependence
For people who are at high risk for developing severe COVID-19 illness and have tested positive for the COVID-19 virus or are unvaccinated and have been exposed to someone who has tested positive, this promising mAb treatment has been shown to help prevent progression of the disease that might otherwise require hospitalization.
These services are currently available. To confirm eligibility for the treatment and to book an appointment, patients can call (601)261-1533 to schedule an appointment or contact their primary care physician’s office to request a referral for the infusion treatment.
If administered within 7 days of the onset of COVID-19 symptoms, the one-time therapy is highly effective in neutralizing the virus and preventing symptoms from worsening. The emergency use authorization provides information on eligibility for mAb treatment. The infusion treatment can take from 20-70 minutes, with an observation time afterward. Treatment is offered regardless of immigration status, health insurance coverage, or ability to pay.
For more information, check out the Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO), and the Mississippi Department of Health website.